CD8A and neoplasm: The prepared vaccine demonstrated a lack of cytotoxicity against BMDCs, elevated cellular uptake, easy migration to lymph nodes, as well as enhanced CD8+ T cell-mediated immune response, which led to the suppression of tumor growth [123].